In an essay published urgently in the international open access journal PloS Medicine, Pulitzer Prize winning author Laurie Garrett warns that if Libya proceeds with the executions of six foreign health workers accused of infecting children with HIV, the appalling injustice will threaten health workers worldwide and endanger their patients in the poorest parts of the world.
Giving the message ‘get tested for AIDS, it’s in fashion’, newly-crowned Miss Universe Zuleyka Rivera Mendzo of Puerto Rico says she was against ‘free sex,’ added she said that the problem is there therefore we have to take care of ourselves.
One year after the Unite for Children. Unite against AIDS campaign, Guinea-Bissau, today launched a pediatric treatment effort against AIDS to ensure that the needs of infected and affected children are met.
In a first-of-its-kind study, UCLA researchers have shown that segments of the HIV-infected population who have little to no consistent outpatient medical care ? and yet are most in need of such services ? are overwhelmingly minorities, the poor and substance abusers.
A prestigious British science journal has spoken out about a trial in Libya involving six foreign medical workers. Five Bulgarian nurses and a Palestinian doctor are accused of deliberately injecting more than 400 children with HIV-infected blood in 1998.
The Bill and Melinda Gates Foundation on Tuesday pledged US$23 million to help Indian health authorities in their efforts to combat HIV. The funds, to be disbursed over the next three years, will be used to “enhance the capacity of the government of India’s HIV prevention response,” Tadataka Yamada of the Foundation’s Global Health Program, said in New Delhi.
Two HIV-positive boys have been forced to leave an orphanage in India’s Gujarat state after staff said they posed an unacceptable risk to the safety of other children, an official said.
Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has granted approval of a new 300 mg single capsule formulation of REYATAZ? (atazanavir sulfate) for the treatment of HIV-1 infection in adults as part of combination therapy. Taken once daily along with ritonavir and food as part of a anti-HIV drug regimen, the REYATAZ 300 mg single capsule formulation can replace two REYATAZ 150 mg capsules for: patients who have previously received anti-HIV medicines, patients who will be receiving tenofovir disoproxil fumarate, and patients who have never taken anti-HIV medicines that require SUSTIVA? (efavirenz) as part of their anti-HIV drug regimen. The REYATAZ single capsule formulation will be available in the United States within seven business days.
Responding to the need to make timely evaluations and decisions when treating treatment experienced HIV patients, Virco (http://www.vircolab.com), a leader in drug resistance testing recently introduced an improved virco(R)TYPE HIV-1 test that rapidly determines the complex phenotypic resistance profiles for darunavir, tipranavir and other antiretroviral (ARV) drugs. Utilizing clinical trial data that was used to support the approval of darunavir and tipranavir, virco(R)TYPE HIV-1 reports now include Clinical Cut-Offs (CCOs) for these recently introduced agents(1). Virco(R)TYPE HIV-1 analyzes patient HIV-1 resistant genotypes using Virco’s large database to quickly and accurately predict phenotypic resistance. This timely determination of phenotypic resistance assists physicians in choosing a drug treatment plan that has the least amount of drug resistance.
A new HIV study shows how competition among the human immune system’s T cells allows the virus to escape destruction and eventually develop into full-blown AIDS. The study, which employs a computer model of simultaneous virus and immune system evolution, also suggests a new strategy for vaccinating against the virus – a strategy that the computer simulations suggest may prevent the final onset of AIDS.